Checkpoint Surgical Inc. – a leader in hand-held, intraoperative neurostimulation technology for nerve protection and repair – received Breakthrough Device designation from the U.S. Food and Drug Administration for the Checkpoint brief electrostimulation therapy (BEST) system.

Eight medical device makers – including a startup that uses virtual reality to treat chronic pain – topped an innovation contest aimed at addressing the opioid crisis, the U.S. FDA said.